The Roles of EET s in Neurological Disorders
CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)
DOI: 10.1002/cns.71121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 08.09.2026. Verfasst von Rong Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Nervous System Diseases, Epoxide Hydrolases, Eicosanoids. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Xiamen, China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Epoxyeicosatrienoic acids (EETs) are bioactive lipid mediators derived from arachidonic acid (ARA) via cytochrome P450 (CYP450) enzymes. They exert pleiotropic effects including anti‐inflammation, anti‐apoptosis, antioxidant activity, and vasodilation. Soluble epoxide hydrolase (sEH) rapidly hydrolyzes EETs to inactive diols, and its inhibition has emerged as a promising strategy to potentiate EET‐mediated benefits. This review synthesizes current evidence on the roles and mechanisms of EETs and sEH in major neurological disorders and discusses translational challenges and future directions.
Methods
A narrative review was conducted to synthesize evidence on the biosynthesis and metabolism of EETs, the expression and regulation of brain cytochrome P450 epoxygenases and sEH, the neuroprotective effects of EETs, and the therapeutic potential of sEH inhibitors, and to identify current limitations and future strategies for sEH‐targeted therapies.
Results
EETs ameliorate multiple neurological disorders through anti‐inflammatory and anti‐apoptotic effects, increased cerebral blood flow, reduced excitotoxicity, decreased dendritic spine loss, reduced oxidative stress, and enhanced neurosteroid secretion. In animal models, sEH inhibition elevates endogenous EET bioavailability, slows progression of various central nervous system diseases, and attenuates brain injury. However, sEH inhibitor development faces several challenges, including species differences in CYP expression, insufficient blood–brain barrier penetration, bleeding risks, failure of some candidates in late‐stage trials, and the limitations of single‐target inhibition.
Conclusions
EETs are endogenous multifaceted neuroprotective mediators that act through convergent anti‐inflammatory, anti‐apoptotic, and vascular mechanisms. sEH inhibition represents a highly attractive yet challenging therapeutic strategy for a wide spectrum of central nervous system disorders. Future progress requires: development of brain‐penetrant or dual‐target sEH inhibitors; identification of EET‐specific G protein‐coupled receptors (GPCRs) and biomarkers for patient stratification; improved preclinical models that better translate to humans; and rigorous clinical evaluation to define safety and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian, China.
- Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, Fujian, China.
- Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Rong Tang, Mengya Li, Banglian Hu, Honghua Zheng, Jing Ding
Förderung
- Natural Science Foundation of Xiamen, China
- National Natural Science Foundation of China
Zitieren
APA
Tang, R., Li, M., Hu, B., Fei, G., Zheng, H., Wang, X., & Ding, J. (2026). The Roles of EET s in Neurological Disorders. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71121
Vancouver
Tang R, Li M, Hu B, Fei G, Zheng H, Wang X, et al. The Roles of EET s in Neurological Disorders. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71121
BibTeX
@article{Tang2026,
author = {Tang, Rong and Li, Mengya and Hu, Banglian and Fei, Guoqiang and Zheng, Honghua and Wang, Xin and Ding, Jing},
title = {The Roles of EET s in Neurological Disorders},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/cns.71121}
}
EUVIMED